BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 35256857)

  • 1. Bioinformatic Analysis of Prognostic Value of Pyroptosis-Related Genes and Its Effect on Immune Cell Infiltration in Pancreatic Adenocarcinoma.
    Wang J; Zhang H; Shao P; Zhang X; Zhou B
    Int J Gen Med; 2022; 15():2311-2319. PubMed ID: 35256857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma.
    Yan C; Niu Y; Li F; Zhao W; Ma L
    J Transl Med; 2022 Oct; 20(1):455. PubMed ID: 36199146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissection of pyroptosis-related prognostic signature and CASP6-mediated regulation in pancreatic adenocarcinoma: new sights to clinical decision-making.
    Zhu J; Shi Y; Lan S; Wang J; Jiang F; Tang C; Cai Y; Pan Z; Jian H; Fang H; Zhang Y; Zhong F
    Apoptosis; 2023 Jun; 28(5-6):769-782. PubMed ID: 36882663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a Prognostic Model Based on Pyroptosis-Related Genes in Pancreatic Adenocarcinoma.
    Su K; Peng Y; Yu H
    Dis Markers; 2022; 2022():9141117. PubMed ID: 35677632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel pyroptosis-associated lncRNA LINC01133 promotes pancreatic adenocarcinoma development via miR-30b-5p/SIRT1 axis.
    Li J; Lin J; Ji Y; Wang X; Fu D; Wang W; Shen B
    Cell Oncol (Dordr); 2023 Oct; 46(5):1381-1398. PubMed ID: 37138146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and comprehensive analysis of a novel prognostic signature associated with pyroptosis molecular subtypes in patients with pancreatic adenocarcinoma.
    Huang Q; Peng X; Li Q; Zhu J; Xue J; Jiang H
    Front Immunol; 2023; 14():1111494. PubMed ID: 36817451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyroptosis regulators exert crucial functions in prognosis, progression and immune microenvironment of pancreatic adenocarcinoma: a bioinformatic and in vitro research.
    Bai Z; Xu F; Feng X; Wu Y; Lv J; Shi Y; Pei H
    Bioengineered; 2022 Jan; 13(1):1717-1735. PubMed ID: 35000541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a Pyroptosis-Related Gene Signature and Effect of Silencing the
    Chen Y; Liu Y; Wang M
    Int J Gen Med; 2022; 15():3199-3213. PubMed ID: 35342302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identify potential prognostic indicators and tumor-infiltrating immune cells in pancreatic adenocarcinoma.
    Shi T; Gao G
    Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35083488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Analysis of Prognostic and Immune Infiltrates for E2F Transcription Factors in Human Pancreatic Adenocarcinoma.
    Liu XS; Gao Y; Liu C; Chen XQ; Zhou LM; Yang JW; Kui XY; Pei ZJ
    Front Oncol; 2020; 10():606735. PubMed ID: 33604289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Analysis of SMC Gene Family Prognostic Value and Immune Infiltration in Patients With Pancreatic Adenocarcinoma.
    Nie H; Wu Y; Ou C; He X
    Front Med (Lausanne); 2022; 9():832312. PubMed ID: 35372377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comprehensive Analysis of Pyroptosis-Related lncRNAs Signature Associated With Prognosis and Tumor Immune Microenvironment of Pancreatic Adenocarcinoma.
    Zhao K; Li X; Shi Y; Lu Y; Qiu P; Deng Z; Yao W; Wang J
    Front Genet; 2022; 13():899496. PubMed ID: 35873495
    [No Abstract]   [Full Text] [Related]  

  • 13. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
    Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
    Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of RNF169 is associated with poor prognosis in pancreatic adenocarcinoma by regulating tumour immune infiltration.
    Wang J; Chen H; Deng Q; Chen Y; Wang Z; Yan Z; Wang Y; Tang H; Liang H; Jiang Y
    Front Genet; 2022; 13():1022626. PubMed ID: 36685833
    [No Abstract]   [Full Text] [Related]  

  • 15.
    Kuang W; Wang X; Ding J; Li J; Ji M; Chen W; Wang L; Yang P
    Front Immunol; 2022; 13():805311. PubMed ID: 35154122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmembrane Protein 170B is a Prognostic Biomarker and Associated With Immune Infiltrates in Pancreatic Adenocarcinoma.
    Zhang Z; Shang J; Dai Z; Yao Y; Shi Y; Zhong D; Liang Y; Lai C; Yang Q; Feng T; Huang X
    Front Genet; 2022; 13():848391. PubMed ID: 35601487
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of Novel Tumor Pyroptosis-Related Antigens and Pyroptosis Subtypes for Developing mRNA Vaccines in Pancreatic Adenocarcinoma.
    Lin Q; Liang L; Wang Q; Wang X; You Y; Rong Y; Zhou Y; Guo X
    Biomedicines; 2024 Mar; 12(4):. PubMed ID: 38672082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KRT7 Overexpression is Associated with Poor Prognosis and Immune Cell Infiltration in Patients with Pancreatic Adenocarcinoma.
    Li Y; Su Z; Wei B; Liang Z
    Int J Gen Med; 2021; 14():2677-2694. PubMed ID: 34188523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Value and the Immune Microenvironment-associated Role of
    Song Y; Wang Y; Yu T; He Y; Wang C; Wang F; Zhou Y
    Anticancer Res; 2023 Dec; 43(12):5393-5408. PubMed ID: 38030175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression profile of Gasdermin C-related genes predicts the prognosis and immunotherapy response of pancreatic adenocarcinoma.
    Xia XH; Yin WJ; Mao JF; Liu P; Qin CD; Hu JJ; Liu SY; Wang CM; Zou DH; Yang HJ; Yu Y; Huang J
    Am J Cancer Res; 2023; 13(4):1240-1258. PubMed ID: 37168356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.